Search
for
Sort by
Research 31–60 of 1000+
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Ophthalmologic Comorbidities in Alopecia Areata
- Central retinal vein occlusion with secondary cilioretinal artery occlusion following oral minoxidil use: A case report and literature review
- The Pharma Market as Reflected by Patents
- Allergic contact dermatitis to topical brimonidine
- Antihelminthic Drugs
- Hormesis and medicine
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- Balint’s syndrome—missed or mistaken?
- Isotretinoin-based treatment in patients with acne: main physiological and psychological effects
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ
- A Filipino with Systemic Lupus Erythematosus-Scleroderma Overlap Syndrome
- Ottawa, Ontario, Canada, February 13–16, 2013
- Short-Term Topical Minoxidil Use Associated with Acute Central Serous Chorioretinopathy: A Case Report
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Reversible Vision Loss With Pituitary Microadenoma Following PRP Injection for Hair Growth: A Rare Case Report and a Mini‐Review of the Literature
- From Hair Loss to Vision Loss: Minoxidil-Associated CRVO in a Young Female
- Acute central serous chorioretinopathy following topical minoxidil use for androgenic alopecia - A case report
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome
- Alterations in Corneal Sensitivity, Staining and Biomechanics of Alopecia Areata Patients: Novel Findings in a Case-Control Study
- Evaluation of Retinal Changes in Women with Different Phenotypes of Polycystic Ovary Syndrome
- Advances in Chitosan-Based Nanoparticles for Drug Delivery
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Insulin resistance is increased in alopecia areata patients
- Cutaneous changes in patients with chronic renal failure on hemodialysis
- Latanoprost-induced Skin Depigmentation
- A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia